Skip to content
OpenCapital
Get started

ANI Pharmaceuticals ANIP Financing Cash Flow

Financing Cash Flow at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$59.06M-50.8%
Viatris logo
ViatrisVTRS
-$203.8M+56.4%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.21M+104%
ALN
Alnylam PharmaceuticalsALNY
$15.71M-65.9%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
-$53.69M-8.8%
Amgen logo
AmgenAMGN
$1.44B+135%

Other financials

Income statement

See full
Revenue$237.5M+20.5%
Gross profit$143.9M+16.0%
Operating income$38.9M+48.5%
Net income$29.5M+88.1%
EPS (diluted)$1.28+85.5%

Balance sheet

See full
Cash & equivalents$311.2M+108%
Total debt$305.3M-3.5%
Total equity$562.3M+34.3%
Total assets$1.4B+10.0%

Cash flow

See full
Operating cash flow$58.4M+66.8%
CapEx$6.1M+146%
Free cash flow$52.3M+60.8%

Valuation

See full
Market cap$1.89B+18.3%
Enterprise value$1.88B+5.8%
P/E20.5×—
P/S2×-0.3×

Profitability

See full
Gross margin60.8%+1.5pp
Operating margin13.4%—
Net margin10%+8.1pp
FCF margin20.7%+10.8pp

Returns & leverage

See full
Return on equity18.8%+15.6pp
Debt / equity0.5×-0.2×
Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANI Pharmaceuticals's financing cash flow?
ANI Pharmaceuticals (ANIP) reported financing cash flow of -$21.62M in Q1 2026.
How has ANI Pharmaceuticals's financing cash flow changed year-over-year?
ANI Pharmaceuticals's financing cash flow decreased by 118.2% year-over-year, from -$9.91M to -$21.62M.
What is the long-term trend for ANI Pharmaceuticals's financing cash flow?
Over 2 years (2021 to 2024), ANI Pharmaceuticals's financing cash flow has grown at a 16.9% compound annual growth rate (CAGR), from $197.62M to $269.85M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.